Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea · Delayed Price · Currency is KRW 9,720.00
-210.00 (-2.11%)
Apr 30, 2026, 3:30 PM KST
Komipharm International Market Cap
Komipharm International has a market cap or net worth of 703.16 billion as of April 30, 2026. Its market cap has increased by 140.80% in one year.
Market Cap
703.16B
Enterprise Value
718.47B
Revenue
52.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,720.00
Market Cap Chart
Since March 1, 2002, Komipharm International's market cap has increased from 94.26B to 703.16B, an increase of 645.98%. That is a compound annual growth rate of 8.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 718.35B | 41.70% |
| Dec 30, 2025 | 506.94B | 89.57% |
| Dec 30, 2024 | 267.41B | -9.03% |
| Dec 28, 2023 | 293.94B | -34.10% |
| Dec 29, 2022 | 446.06B | -18.67% |
| Dec 30, 2021 | 548.45B | -36.13% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 69.62T |
| Celltrion | 43.39T |
| ALTEOGEN | 20.15T |
| Samsung Epis Holdings | 14.13T |
| Huons Global | 771.23B |
| JW Pharmaceutical | 741.75B |
| Medy-Tox | 704.68B |
| Curexo | 692.34B |